Trinity Biotech plc (TRIB) Tops Q2 EPS by 1c

Trinity Biotech plc (NASDAQ: TRIB) reported Q2 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $20.8 million versus the consensus estimate of $21.19 million.

For earnings history and earnings-related data on Trinity Biotech plc (TRIB) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
• Surgery Partners agrees to sell Idaho Falls hospitals for $1.15B